TREACE MEDICAL CONCEPTS INC (TMCI) Fundamental Analysis & Valuation

NASDAQ:TMCI • US89455T1097

1.43 USD
+0.04 (+2.88%)
At close: Mar 6, 2026
1.47 USD
+0.04 (+2.8%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This TMCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall TMCI gets a fundamental rating of 2 out of 10. We evaluated TMCI against 184 industry peers in the Health Care Equipment & Supplies industry. TMCI has a bad profitability rating. Also its financial health evaluation is rather negative. TMCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. TMCI Profitability Analysis

1.1 Basic Checks

  • TMCI had negative earnings in the past year.
  • TMCI had a negative operating cash flow in the past year.
  • TMCI had negative earnings in each of the past 5 years.
  • In the past 5 years TMCI always reported negative operating cash flow.
TMCI Yearly Net Income VS EBIT VS OCF VS FCFTMCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M -50M

1.2 Ratios

  • TMCI has a Return On Assets (-25.49%) which is comparable to the rest of the industry.
  • TMCI has a Return On Equity of -56.18%. This is comparable to the rest of the industry: TMCI outperforms 47.28% of its industry peers.
Industry RankSector Rank
ROA -25.49%
ROE -56.18%
ROIC N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
TMCI Yearly ROA, ROE, ROICTMCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

  • With an excellent Gross Margin value of 79.87%, TMCI belongs to the best of the industry, outperforming 92.93% of the companies in the same industry.
  • TMCI's Gross Margin has been stable in the last couple of years.
  • TMCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
TMCI Yearly Profit, Operating, Gross MarginsTMCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TMCI Health Analysis

2.1 Basic Checks

  • TMCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TMCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TMCI Yearly Shares OutstandingTMCI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
TMCI Yearly Total Debt VS Total AssetsTMCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • TMCI has an Altman-Z score of -0.31. This is a bad value and indicates that TMCI is not financially healthy and even has some risk of bankruptcy.
  • TMCI has a Altman-Z score (-0.31) which is in line with its industry peers.
  • TMCI has a Debt/Equity ratio of 0.62. This is a neutral value indicating TMCI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.62, TMCI is not doing good in the industry: 64.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z -0.31
ROIC/WACCN/A
WACC10.85%
TMCI Yearly LT Debt VS Equity VS FCFTMCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that TMCI has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 3.37, TMCI is doing good in the industry, outperforming 60.87% of the companies in the same industry.
  • A Quick Ratio of 2.36 indicates that TMCI has no problem at all paying its short term obligations.
  • TMCI has a Quick ratio (2.36) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.36
TMCI Yearly Current Assets VS Current LiabilitesTMCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TMCI Growth Analysis

3.1 Past

  • The earnings per share for TMCI have decreased strongly by -10.59% in the last year.
EPS 1Y (TTM)-10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.22% on average over the next years.
  • Based on estimates for the next years, TMCI will show a small growth in Revenue. The Revenue will grow by 2.59% on average per year.
EPS Next Y7.4%
EPS Next 2Y7.07%
EPS Next 3Y4.22%
EPS Next 5YN/A
Revenue Next Year-2.52%
Revenue Next 2Y2.43%
Revenue Next 3Y2.59%
Revenue Next 5YN/A

3.3 Evolution

TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. TMCI Valuation Analysis

4.1 Price/Earnings Ratio

  • TMCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TMCI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMCI Price Earnings VS Forward Price EarningsTMCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMCI Per share dataTMCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.07%
EPS Next 3Y4.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMCI Dividend Analysis

5.1 Amount

  • No dividends for TMCI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TMCI Fundamentals: All Metrics, Ratios and Statistics

TREACE MEDICAL CONCEPTS INC

NASDAQ:TMCI (3/6/2026, 8:00:02 PM)

After market: 1.47 +0.04 (+2.8%)

1.43

+0.04 (+2.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-27
Earnings (Next)05-06
Inst Owners56.35%
Inst Owner Change-9.59%
Ins Owners24.03%
Ins Owner Change-0.4%
Market Cap92.36M
Revenue(TTM)N/A
Net Income(TTM)-50.11M
Analysts50.91
Price Target4.08 (185.31%)
Short Float %7.7%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.88%
Min EPS beat(2)4.79%
Max EPS beat(2)8.96%
EPS beat(4)4
Avg EPS beat(4)26.76%
Min EPS beat(4)4.79%
Max EPS beat(4)74.58%
EPS beat(8)7
Avg EPS beat(8)13.87%
EPS beat(12)10
Avg EPS beat(12)14.08%
EPS beat(16)12
Avg EPS beat(16)-130.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)-1.01%
Revenue beat(4)1
Avg Revenue beat(4)-0.75%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)0.3%
Revenue beat(8)5
Avg Revenue beat(8)0.36%
Revenue beat(12)8
Avg Revenue beat(12)1.09%
Revenue beat(16)12
Avg Revenue beat(16)2.15%
PT rev (1m)-17.31%
PT rev (3m)-26.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS3.39
BVpS1.38
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.49%
ROE -56.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.87%
FCFM N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
F-Score3
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 141.2%
Cap/Sales 6.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 2.36
Altman-Z -0.31
F-Score3
WACC10.85%
ROIC/WACCN/A
Cap/Depr(3y)349.5%
Cap/Depr(5y)305.94%
Cap/Sales(3y)7.38%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y7.4%
EPS Next 2Y7.07%
EPS Next 3Y4.22%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.01%
Revenue Next Year-2.52%
Revenue Next 2Y2.43%
Revenue Next 3Y2.59%
Revenue Next 5YN/A
EBIT growth 1Y22.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.32%
EBIT Next 3Y23.06%
EBIT Next 5Y14.51%
FCF growth 1Y49.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.98%
OCF growth 3YN/A
OCF growth 5YN/A

TREACE MEDICAL CONCEPTS INC / TMCI FAQ

Can you provide the ChartMill fundamental rating for TREACE MEDICAL CONCEPTS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TMCI.


What is the valuation status of TREACE MEDICAL CONCEPTS INC (TMCI) stock?

ChartMill assigns a valuation rating of 0 / 10 to TREACE MEDICAL CONCEPTS INC (TMCI). This can be considered as Overvalued.


Can you provide the profitability details for TREACE MEDICAL CONCEPTS INC?

TREACE MEDICAL CONCEPTS INC (TMCI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for TREACE MEDICAL CONCEPTS INC?

The Earnings per Share (EPS) of TREACE MEDICAL CONCEPTS INC (TMCI) is expected to grow by 7.4% in the next year.